Abstract
Hypertension is rapidly becoming a major public health burden in sub-Saharan/Africa but awareness, treatment, and control is lagging behind. We analysed cross-sectional data from Ghana (West-Africa) to examine factors associated with awareness, treatment, and control of hypertension. The overall prevalence of hypertension was 29.4%. Of these, 34% were aware of their condition, 28% were receiving treatment, and 6.2% were controlled below SBP/DBP <140/90 mmHg. Multivariate analysis showed that old age was independently associated with higher hypertension awareness: 35–49-year-olds (odds ratio (OR)=2.57, 95% (confidence interval) CI: 1.26–5.22), ⩾50-year-olds (OR=6.14, CI: 2.98–12.64) compared with 16–34-year-olds. Old age: ⩾50-year-olds (OR: 6.25, 95% CI: 2.87–13.62), trading (OR=2.46, 95% CI: 1.17–5.17), and overweight (OR=1.85, 95% CI: 1.02, 3.34) were independently associated with pharmacological treatment of hypertension. Trading (OR=2.51, 95% CI: 1.03–7.40) was independently associated with adequate blood pressure (BP) control but old age: ⩾50-year-olds (OR=0.11, 95% CI: 0.01–0.60) was independently associated with inadequate BP control. The identified factors provide important information for improving BP control among this population. Given the high cost of hypertension medication relative to income, increasing awareness and simple preventive measures such as promotion of physical activity, normalising body weight and reduction of salt intake, present the best hope for reducing the impact of hypertension on morbidity and mortality.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
Purchase on Springer Link
Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Murray CJ, Lopez AD . Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349:i: 1269–1276; ii: 1436–1442.
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J . Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217–223.
Shaper AG, Wright DH, Kyobe J . Blood pressure and body build in three nomadic tribes of northern Kenya. East Afr Med J 1969; 46: 273–281.
Edwards R, Unwin N, Mugusi F, Whiting D, Rashid S, Kissima J et al. Hypertension prevalence and care in an urban and rural area of Tanzania. J Hypertens 2000; 18: 145–152.
Cappuccio FP, Micah FB, Emmett L, Kerry SM, Antwi S, Martin-Peprah R et al. Prevalence, detection, management, and control of hypertension in Ashanti, West Africa. Hypertension 2004; 43: 1017–1022.
Amoah AG . Hypertension in Ghana: a cross-sectional community prevalence study in greater Accra. Ethn Dis 2003; 13: 310–315.
Bovet P, Ross AG, Gervasoni JP, Mkamba M, Mtasiwa DM, Lengeler C et al. Distribution of blood pressure, body mass index and smoking habits in the urban population of Dar es Salaam, Tanzania, and associations with socioeconomic status. Int J Epidemiol 2002; 31: 240–247.
Steyn K, Gaziano TA, Bradshaw D, Laubscher R, Fourie J . South African Demographic and Health Coordinating Team. Hypertension in South African adults: results from the Demographic and Health Survey, 1998. J Hypertens 2001; 19: 1717–1725.
Ibrahim MM, Rizk H, Appel LJ, el Aroussy W, Helmy S, Sharaf Y et al. Hypertension prevalence, awareness, treatment, and control in Egypt. Results from the Egyptian National Hypertension Project (NHP). NHP investigative team. Hypertension 1995; 26: 886–890.
Walker RW, McLarty DG, Kitange HM, Whiting D, Masuki G, Mtasiwa DM et al. Stroke mortality in urban and rural Tanzania. Adult morbidity and mortality project. Lancet 2000; 355: 1684–1687.
Whelton PK, Beevers DG, Sonkodi S . Strategies for improvement of awareness, treatment and control of hypertension: results of a panel discussion. J Hum Hypertens 2004; 18: 563–565.
Wang Y, Wang QJ . The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. Arch Intern Med 2004; 164: 2126–2134.
Muntner P, Gu D, Wu X, Duan X, Wenqi G, Whelton PK et al. Factors associated with hypertension awareness, treatment, and control in a representative sample of the Chinese population. Hypertension 2004; 43: 578–585.
Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004; 43: 10–17.
Hajjar I, Kotchen TA . Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003; 290: 199–206.
Primatesta P, Poulter N . Improvement in hypertension management in England: Results from the Health Survey for England 2003 (in press).
Cifkova R, Skodova Z, Lanska V, Adamkova V, Novozamska E, Jozifova M et al. Prevalence, awareness, treatment, and control of hypertension in the Czech Republic. Results of two nationwide cross-sectional surveys in 1997/1998 and 2000/2001, Czech Post-MONICA Study. J Hum Hypertens 2004; 18: 571–579.
Psaltopoulou T, Orfanos P, Naska A, Lenas D, Trichopoulos D, Trichopoulou A . Prevalence, awareness, treatment and control of hypertension in a general population sample of 26,913 adults in the Greek EPIC study. Int J Epidemiol 2004; 33: 1345–1352.
Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P et al. InterASIA Collaborative Group. The International Collaborative Study of Cardiovascular Disease in ASIA. Prevalence, awareness, treatment, and control of hypertension in china. Hypertension 2002; 40: 920–927.
Marques-Vidal P, Tuomilehto J . Hypertension awareness, treatment and control in the community: is the ‘rule of halves’ still valid? J Hum Hypertens 1997; 11: 213–220.
Chen R, Tunstall-Pedoe H, Morrison C, Connaghan J, A'Brook R . Trends and social factors in blood pressure control in Scottish MONICA surveys 1986–1995: the rule of halves revisited. J Hum Hypertens 2003; 17: 751–759.
Ohene Buabeng K, Matowe L, Plange-Rhule J . Unaffordable drug prices: the major cause of non-compliance with hypertension medication in Ghana. J Pharm Pharm Sci 2004; 7: 350–352.
Acknowledgements
We thank Professor Raj Bhopal (University of Edinburgh), A de Jonge (Nijmegen University), and Dr. Ken Redekop (Erasmus Medical Centre) for their very useful comments, which helped to improve the earlier version of this paper. We are also indebted to the anonymous referee who provided comments that helped to improved the earlier version of this paper. This project was supported by the Health Research and Development Council of the Netherlands (ZonMw).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Agyemang, C., Bruijnzeels, M. & Owusu-Dabo, E. Factors associated with hypertension awareness, treatment, and control in Ghana, West Africa. J Hum Hypertens 20, 67–71 (2006). https://doi.org/10.1038/sj.jhh.1001923
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001923
Keywords
This article is cited by
-
Prevalence and risk factors of hypertension among public servants in Ejisu-Juaben municipality, Ghana
BMC Research Notes (2023)
-
Perceived barriers and enablers influencing health extension workers toward home-based hypertension screening in rural northwest Ethiopia: interpretive descriptive study
BMC Health Services Research (2022)
-
Health and socioeconomic risk factors for overnight admission among older adults in Ghana
Journal of Population Ageing (2022)
-
What do we need to know? Data sources to support evidence-based decisions using health technology assessment in Ghana
Health Research Policy and Systems (2020)
-
Conquering hypertension in Vietnam—solutions at grassroots level: study protocol of a cluster randomized controlled trial
Trials (2020)